Albert David Limited (NSE:ALBERTDAVD)
India · Delayed Price · Currency is INR 750.60
-19.70 (-2.56%)
Dec 15, 2025, 3:29 PM IST
Albert David Market Cap
Albert David has a market cap or net worth of 4.29 billion as of December 15, 2025. Its market cap has decreased by -41.10% in one year.
Market Cap
4.29B
Enterprise Value
1.86B
Revenue
3.16B
Ranking
n/a
PE Ratio
n/a
Stock Price
750.60
Market Cap Chart
Since October 30, 2001, Albert David's market cap has increased from 80.47M to 4.29B, an increase of 5,234.04%. That is a compound annual growth rate of 17.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 4.38B | -42.05% |
| Dec 31, 2024 | 7.56B | 35.71% |
| Dec 29, 2023 | 5.57B | 71.95% |
| Dec 30, 2022 | 3.24B | -6.10% |
| Dec 31, 2021 | 3.45B | 36.82% |
| Dec 31, 2020 | 2.52B | 8.10% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.30T |
| Divi's Laboratories | 1.71T |
| Cipla | 1.23T |
| Apollo Hospitals Enterprise | 1.02T |
| Zydus Lifesciences | 934.94B |
| Mankind Pharma | 899.42B |
| Aurobindo Pharma | 694.12B |
| Alkem Laboratories | 673.27B |